From: Biodistribution and dosimetry of the GluN2B-specific NMDA receptor PET radioligand (R)-[11C]Me-NB1
Organs | h (male) (µSv/MBq) | h (female) (µSv/MBq) |
---|---|---|
Adrenals | 4.4 | 5.9 |
Brain | 6.2 | 8.1 |
Breasts | – | 2.4 |
Esophagus | 2.7 | 3.6 |
Gallbladder Wall | 4.3 | 4.1 |
Left colon | 2.8 | 3.6 |
Small Intestine | 2.9 | 3.4 |
Stomach Wall | 6.1 | 10.5 |
Right colon | 2.8 | 3.4 |
Rectum | 3.7 | 4.1 |
Heart Wall | 6.9 | 9.1 |
Kidneys | 10.5 | 12.9 |
Liver | 11.9 | 11.3 |
Lungs | 4.7 | 7.0 |
Ovaries | – | 3.5 |
Pancreas | 14.3 | 22.6 |
Prostate | 4.5 | – |
Salivary Gland | 2.1 | 2.8 |
Bone Marrow | 3.9 | 4.6 |
Osteogenic Cells | 3.1 | 3.4 |
Spleen | 10.5 | 14.6 |
Testes | 2.2 | – |
Thymus | 2.3 | 3.4 |
Thyroid | 6.3 | 8.3 |
Urin. Bladder Wall | 53.6 | 22.3 |
Uterus | – | 4.2 |
Remainder of Body | 2.7 | 3.5 |
Effective Dose coefficient (µSv/MBq) | 6.0 |